Zeroharm Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 28-10-2024
- Paid Up Capital ₹ 1.86 M
as on 28-10-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 28-10-2024
- Revenue 323.55%
(FY 2023)
- Profit -50.55%
(FY 2023)
- Ebitda -50.48%
(FY 2023)
- Net Worth -22.57%
(FY 2023)
- Total Assets -21.98%
(FY 2023)
About Zeroharm Sciences
The Corporate was formerly known as Nutranxt Biotech Private Limited. The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.86 M.
The company currently has active open charges totaling ₹2.00 Cr.
Manmahesh Kantipudi, Sudhakar Darbarwar, Sachin Darbarwar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2020PTC145072
- Company No.
145072
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zeroharm Sciences Private Limited offer?
Zeroharm Sciences Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Capsules, Ayurvedic,Herbal Products & Medicine, Ayurvedic Tablets, Medical Laboratory Instruments, VTM Kit Raw Materials, Diabetic Herbal Medicine, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Ayurvedic Powder and Medicinal Herbs.
Who are the key members and board of directors at Zeroharm Sciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manmahesh Kantipudi  | Director | 21-Dec-2021 | Current |
| Sudhakar Darbarwar | Director | 21-Oct-2020 | Current |
Sachin Darbarwar  | Additional Director | 20-Apr-2023 | Current |
| Swetha Ravikanti | Director | 10-Mar-2021 | Current |
| Sahil Noorani | Director | 05-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Zeroharm Sciences.
Zeroharm Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 323.55% increase. The company also saw a substantial fall in profitability, with a 50.55% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zeroharm Sciences?
In 2023, Zeroharm Sciences had a public holding of 37.59%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zeroharm Prerna Private LimitedActive 29 daysManmahesh Kantipudi and Sachin Darbarwar are mutual person
- Nutri Food And Tech Ventures LlpActive 2 years 11 months
Sachin Darbarwar and Swetha Ravikanti are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Mar 2022 | ₹2.00 Cr | Open |
How Many Employees Work at Zeroharm Sciences?
Zeroharm Sciences has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeroharm Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeroharm Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
